Apex works with a select council of top clinicians across digital health, AI, and medtech to validate, refine, and signal the most promising healthcare companies — before capital moves.
Every company we back is clinically filtered through the Apex MD Council —
with founding members from institutions like Stanford, Columbia, and leading medtech accelerators — ensuring only the highest-signal opportunities reach the market.
The Council is invite-only, keeping insights sharp, current, and trusted by top investors across the ecosystem.
